You are here

Novarts

Novartis-backed Penn study proposes boosting CAR-T responses in CLL by waking up 'war weary' T cells

Fierce Biotech

Tue, 08/17/21 - 10:20 am

Novartis hands off NASH drug to biotech collaborator, also plans to build new Basel production unit

Endpoints

Tue, 09/1/20 - 11:05 am

Boston Pharmaceuticals

US Novartis arm smacked with $110 million gender discrimination class action

BioPharma Dive

Wed, 03/18/15 - 11:06 am

gender discrimination